Top Tweets for #ipca()*********
#Ipca Laboratories Ltd.
IPCA Laboratories: The Next Growth Story May Already Be Under Construction
At first glance, IPCA Laboratories looks like a pharma company that simply had a very good FY26. But the Annual Report tells a more interesting story. IPCA is quietly changing the quality of its business. It is integrating Unichem, simplifying its manufacturing footprint, increasing R&D intensity, expanding into complex products and preparing a biosimilar platform — while its existing domestic and international businesses continue to grow. The interesting question is not whether IPCA is growing, but what the company could look like once these investments start compounding together.
1. Unichem could become much more than an acquisition
IPCA's 52.67% ownership of Unichem gives it access to a much larger formulations and international platform. Unichem has subsidiaries and operations across the US, UK, Ireland, South Africa, Brazil, China and other markets, creating opportunities for manufacturing, product and distribution synergies. The turnaround is already visible: Unichem had moved from losses to profitability after becoming part of the IPCA group, and the integration now provides a much larger base from which IPCA can grow.
2. IPCA is becoming more selective about where it puts capital
One of the less obvious changes is that IPCA is not simply adding factories everywhere. It has been reducing its manufacturing footprint while investing in more strategic capabilities. The company is effectively moving from more assets to better assets — focusing capital on APIs, complex formulations, R&D and newer technologies where returns could be higher.
3. R&D is becoming a bigger part of the story
IPCA spent around ₹246 crore on R&D in FY26, and the focus is moving beyond conventional generics toward complex APIs, differentiated formulations, NDDS and developed-market products. The company's investment in biologics and a biosimilar manufacturing platform adds another layer of optionality. If even a portion of this pipeline succeeds, IPCA could gradually move up the value chain.
4. The domestic business still has plenty of runway
The domestic branded formulation business remains an important growth engine. But the opportunity is increasingly about better penetration rather than simply adding products — strengthening brands, expanding specialist coverage and taking the portfolio deeper into the Indian market.
5. The global opportunity is getting larger
IPCA already sells across 100+ countries, while exports account for a significant portion of the business. The next phase could come from taking its own products, dossiers and API capabilities deeper into international markets, particularly through its expanding network of subsidiaries.
And then comes the financial leverage — without relying heavily on financial debt
FY26 standalone income reached ₹7,431 crore, EBITDA before depreciation/interest/tax was about ₹1,847 crore, and PAT reached ₹1,133 crore. More importantly, this has been accompanied by a significant improvement in earnings over the last few years.
The bigger picture
IPCA is gradually moving through four stages:
Indian Pharma Franchise → Unichem Integration → Global & Complex Products → R&D/Biosimilar Optionality
That is what makes IPCA interesting.
The company is no longer just trying to sell more medicines. It is trying to build a more integrated pharma platform — combining brands + APIs + international markets + Unichem + R&D + complex products + biologics.
The real question for investors
Can all these pieces start working together and create a much larger earnings engine over the next 3–5 years?
That is where the IPCA story becomes much more interesting than the FY26 numbers alone suggest.
#Dinheiro #finanças #financeiro #economia #selic #ipca #pib #eleições2026
A economia brasileira entrou em uma fase de maior desaceleração.
https://t.co/jcBFnbWHKQ
#Dinheiro #finanças #financeiro #economia #selic #ipca #pib #eleições2026
A economia brasileira entrou em uma fase de maior desaceleração.
https://t.co/FA6V97BiIn
May this festival inspire us to protect our environment and nurture Mother Earth, just as Lord Krishna nurtured Vrindavan.
.
Wishing you all a joyful, green and waste-free Janmashtami!
.
#HappyJanmashtami #SustainableFestival #WasteManagement #GoGreen #IPCA
🚀 Stocks nearing fresh 52-week highs:
📈 IFCI: ₹97.72 | High: ₹99.49
📈 IPCALAB: ₹1,955.80 | High: ₹2,001.50
📈 LENSKART: ₹669.25 | High: ₹678.40
Momentum building! #Stocks #IndianMarkets #52WeekHigh #IFCI #IPCA #Lenskart #NSE #BSE #Investing
📊 COMO A ECONOMIA BRASILEIRA CHEGA AO SEGUNDO SEMESTRE DE 2026?
Confira a versão completa do nosso Boletim de Conjuntura Econômica de agosto no link da bio!
#Economia #IPEAD #Desemprego #IPCA #Inflação #MercadoDeTrabalho #CestaBásica #Petróleo #RealEstate
KUNAL PARAR ADVISES AVOIDING IPCA LABORATORIES
કુનાલ પરારે આપી IPCA LABORATORIESમાં અવોઈડની સલાહ
#ipcalaboratories #ipca #stockmarket #sharemarket #kunalparar #avoid #stockstrategy #investing #trading #marketnews @KkunalP @theyashbhatt
Chennai: The Indian Pest Control Association (#IPCA) on Friday commenced its 59th annual convention, #INDIAPEST2026, in Chennai, bringing together pest management professionals, government agencies, researchers, policymakers and global experts to discuss the future of the sector.
https://t.co/fAaVmPCX7S
Top #Buzzers At 11 AM
#NMDC Steel
#Infosys
#IPCA Labs
#TCS
#Embassy REIT
#Lenskart
#Azad Engineering
@Hormaz_Fatakia tells you why
#CNBCTV18Market
#MarketsWithBS | #Ipca surges 11% in tepid market, nears 52-week high on healthy #Q1results
#markets #sharemarket #StockMarketNews
https://t.co/BYQm0OHdtb
#WATCH | Why is IPCA Laboratories’ share price rallying today?
Strong Q1 results and upgraded FY27 revenue growth and EBITDA margin guidance are driving the stock higher. @Meryldsouza_ explains.
#IPCALaboratories #IPCA #StockMarket #Q1Results #MerylDsouza #ETNOW
#MarketAlert | IPCA Laboratories rises 6.94% in intraday trade to ₹1,854.60.
#IPCALaboratories #IPCA #MarketAlert #Stocks #StockMarket
Inv PPT and press release:
IPCA Labs
Susan Electricals
Kingfa Science and Technology
IPCA Labs
#IPCA
#IPCALabs
Concall pointers:
Increases both revenue and EBITDA margins guidance for FY27 after a very strong Q1FY27
Raises revenue guidance from 12-13% to 14-16% and might have more upside from this guidance as well
OPM guidance raised from 22% to 23%+
In next 3 years, OPM can move to 26%+ with standalone OPM has potential to reach 30%
15-17% growth guidance for US business for next 2 years
Domestic growth to be at 12-13%
Susan Electricals
#Susan
#SusanElectricals
Extremely strong Q1FY27 with highest ever revenue, EBITDA, PBT and PAT in comps history
Record set
Q1 is the leanest quarter
Rev at 95cr vs 25cr⏫279%
EBITDA at 11.3cr⏫980%
OPM at 11.9% vs 4%
PAT at 6.4cr vs -0.41cr
Unexecuted orderbook at 142cr
To be executed in next 3 months
Pipeline at 150cr providing strong visibility for near term growth
Capex of 4500 kmpa will increase capacity from 7500 kmpa to 12000 kmpa ⏫60% increase
Feb 2027 commisioning
High margin product mix+
Operating leverage
Kingfa Science and Technology
#Kingfa
#KingfaScience
Highest ever revenue, EBITDA, PBT and PAT in comps history
Record quarter with record margins
Rev at 689cr vs 462cr
EBITDA at 111cr vs 58cr⏫93%
OPM at 16% vs 13%
PBT at 108cr vs 54cr⏫100%
PAT at 80cr vs 40cr ⏫100%
20rs final dividend
Domestic sales 92%
Exports 8%
Good to excellent results so far :
IPCA Labs (#IPCA #IPCALabs)
Clean beat across the board — solid QoQ + YoY growth with nice margin expansion.
Rev 2788 cr (vs 2308), PBT 572 cr (vs 330), PAT 402 cr (vs 233). Looking healthy.
Kernex MicroSystems (#Kernex #KernexMicro)
Absolute blockbuster quarter. Numbers jumped hard.
Rev 503 cr (vs 56), EBITDA 163 cr (+1192% YoY, +55% QoQ), OPM 32%, PAT 110 cr (vs 7). Wild print.
Amagi Media Labs (#Amagi)
Decent showing.
Rev 437 cr (vs 330), PBT 40 cr (vs 6.5), PAT 34 cr (vs 4).
TVS Srichakra (#TVSSrichakra)
One of the better tyre names this season.
Rev up ~30% to 1068 cr, PBT 45 cr (vs 20), PAT 34 cr (vs 13).
Minda Corp (#MindaCorp)
Good YoY progress (small QoQ dip).
Rev 1846 cr, PBT 113 cr, PAT 206 cr.
Last Seen Hashtags on Sotwe
novinha boquete
Seen from Brazil
soiling
Seen from United States
SkylarVox
Seen from Algeria
nolimits()*+filter:videos(*)
Seen from Sweden
ometv
Seen from Chile
izmittraveſti
Seen from Germany
momson()*+*+*+filter:native_video
Seen from United States
สาวใหญ่รับงาน
Seen from Thailand
anal
Seen from France
สำรองน้ำมัน
Seen from United States
Most Popular Users
Elon Musk 
@elonmusk
241.6M followers
Barack Obama
@barackobama
119M followers
Cristiano Ronaldo
@cristiano
114.2M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.2M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.4M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
89.9M followers
Taylor Swift
@taylorswift13
83.8M followers
Lady Gaga
@ladygaga
75.3M followers
Virat Kohli
@imvkohli
73.1M followers
Kim Kardashian
@kimkardashian
70.8M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
66.1M followers
Bill Gates
@billgates
65M followers
Selena Gomez
@selenagomez
62.9M followers
The Ellen Show
@theellenshow
62.3M followers
CNN
@cnn
61.8M followers
X
@x
60.7M followers